Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Proteins ; 88(3): 440-448, 2020 03.
Article in English | MEDLINE | ID: mdl-31587363

ABSTRACT

Lysosomal acid lipase (LAL) plays an important role in lipid metabolism by performing hydrolysis of triglycerides and cholesteryl esters in the lysosome. Based upon characteristics of LAL purified from human liver, it has been proposed that LAL is a proprotein with a 55 residue propeptide that may be essential for proper folding, intracellular transport, or enzymatic function. However, the biological significance of such a propeptide has not been fully elucidated. In this study, we have performed a series of studies in cultured HepG2 and HeLa cells to determine the role of the putative propeptide. However, by Western blot analysis and subcellular fractionation, we have not been able to identify a cleaved LAL lacking the N-terminal 55 residues. Moreover, mutating residues surrounding the putative cleavage site at Lys76 ↓ in order to disrupt a proteinase recognition sequence, did not affect LAL activity. Furthermore, forcing cleavage at Lys76 ↓ by introducing the optimal furin cleavage site RRRR↓EL between residues 76 and 77, did not affect LAL activity. These data, in addition to bioinformatics analyses, indicate that LAL is not a proprotein. Thus, it is possible that the previously reported cleavage at Lys76 ↓ could have resulted from exposure to proteolytic enzymes during the multistep purification procedure.


Subject(s)
Hymecromone/analogs & derivatives , Lysosomes/enzymology , Sterol Esterase/chemistry , Amino Acid Sequence , Enzyme Assays , Gene Expression , HeLa Cells , Hep G2 Cells , Humans , Hymecromone/chemistry , Hymecromone/metabolism , Kinetics , Lysosomes/chemistry , Models, Molecular , Mutation , Plasmids/chemistry , Plasmids/metabolism , Protein Structure, Secondary , Proteolysis , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Alignment , Sequence Homology, Amino Acid , Sterol Esterase/genetics , Sterol Esterase/metabolism , Substrate Specificity
2.
Hum Mol Genet ; 28(18): 3043-3052, 2019 09 15.
Article in English | MEDLINE | ID: mdl-31131398

ABSTRACT

Hydrolysis of cholesteryl esters and triglycerides in the lysosome is performed by lysosomal acid lipase (LAL). In this study we have investigated how 23 previously identified missense mutations in the LAL gene (LIPA) (OMIM# 613497) affect the structure of the protein and thereby disrupt LAL activity. Moreover, we have performed transfection studies to study intracellular transport of the 23 mutants. Our main finding was that most pathogenic mutations result in defective enzyme activity by affecting the normal folding of LAL. Whereas, most of the mutations leading to reduced stability of the cap domain did not alter intracellular transport, nearly all mutations that affect the stability of the core domain gave rise to a protein that was not efficiently transported from the endoplasmic reticulum (ER) to the Golgi apparatus. As a consequence, ER stress was generated that is assumed to result in ER-associated degradation of the mutant proteins. The two LAL mutants Q85K and S289C were selected to study whether secretion-defective mutants could be rescued from ER-associated degradation by the use of chemical chaperones. Of the five chemical chaperones tested, only the proteasomal inhibitor MG132 markedly increased the amount of mutant LAL secreted. However, essentially no increased enzymatic activity was observed in the media. These data indicate that the use of chemical chaperones to promote the exit of folding-defective LAL mutants from the ER, may not have a great therapeutic potential as long as these mutants appear to remain enzymatically inactive.


Subject(s)
Mutation, Missense , Sterol Esterase/genetics , Sterol Esterase/metabolism , Amino Acid Sequence , Cells, Cultured , Computational Biology/methods , Endoplasmic Reticulum Stress , Enzyme Activation , Humans , Models, Molecular , Protein Conformation , Protein Transport , Proteolysis , Sterol Esterase/biosynthesis , Sterol Esterase/chemistry , Structure-Activity Relationship
3.
Mol Genet Metab ; 123(2): 169-176, 2018 02.
Article in English | MEDLINE | ID: mdl-29196158

ABSTRACT

Lysosomal acid lipase hydrolyzes cholesteryl esters and triglycerides contained in low density lipoprotein. Patients who are homozygous or compound heterozygous for mutations in the lysosomal acid lipase gene (LIPA), and have some residual enzymatic activity, have cholesteryl ester storage disease. One of the clinical features of this disease is hypercholesterolemia. Thus, patients with hypercholesterolemia who do not carry a mutation as a cause of autosomal dominant hypercholesterolemia, may actually have cholesteryl ester storage disease. In this study we have performed DNA sequencing of LIPA in 3027 hypercholesterolemic patients who did not carry a mutation as a cause of autosomal dominant hypercholesterolemia. Functional analyses of possibly pathogenic mutations and of all mutations in LIPA listed in The Human Genome Mutation Database were performed to determine the pathogenicity of these mutations. For these studies, HeLa T-REx cells were transiently transfected with mutant LIPA plasmids and Western blot analysis of cell lysates was performed to determine if the mutants were synthesized in a normal fashion. The enzymatic activity of the mutants was determined in lysates of the transfected cells using 4-methylumbelliferone-palmitate as the substrate. A total of 41 mutations in LIPA were studied, of which 32 mutations were considered pathogenic by having an enzymatic activity <10% of normal. However, none of the 3027 hypercholesterolemic patients were homozygous or compound heterozygous for a pathogenic mutation. Thus, cholesteryl ester storage disease must be a very rare cause of hypercholesterolemia in Norway.


Subject(s)
Cholesterol Ester Storage Disease/epidemiology , Cholesterol Ester Storage Disease/genetics , Hypercholesterolemia/physiopathology , Mutation , Sterol Esterase/genetics , Adult , Cholesterol Ester Storage Disease/enzymology , Female , HeLa Cells , Homozygote , Humans , Male , Middle Aged , Norway/epidemiology , Phenotype , Prevalence
SELECTION OF CITATIONS
SEARCH DETAIL
...